Persistence Capital sells Access Genomics to Igenomix

Spanish biotechnology company Igenomix has acquired Access Genomics, a Toronto-based genomics company focused on reproductive healthcare.

18 December 2020•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles